U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
ZELMINEMAB
INN  
Official Name English
IMMUNOGLOBULIN G1 (300-GLYCINE), ANTI-(HUMAN PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE RECEPTOR PAC1) (HUMAN MONOCLONAL 29G4V22 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 29G4V22 .KAPPA.-CHAIN, DIMER
Common Name English
zelminemab [INN]
Common Name English
Code System Code Type Description
CAS
2225850-33-7
Created by admin on Sat Dec 16 14:38:47 GMT 2023 , Edited by admin on Sat Dec 16 14:38:47 GMT 2023
PRIMARY
FDA UNII
KTN6S97T6D
Created by admin on Sat Dec 16 14:38:47 GMT 2023 , Edited by admin on Sat Dec 16 14:38:47 GMT 2023
PRIMARY
NCI_THESAURUS
C171843
Created by admin on Sat Dec 16 14:38:47 GMT 2023 , Edited by admin on Sat Dec 16 14:38:47 GMT 2023
PRIMARY
INN
11091
Created by admin on Sat Dec 16 14:38:47 GMT 2023 , Edited by admin on Sat Dec 16 14:38:47 GMT 2023
PRIMARY
ACTIVE MOIETY
ZELMINEMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966